A DOUBLE-BLIND, PLACEBO-CONTROLLED, 4-ARM, PHASE 2B STUDY TO ASSESS THE EFFICACY AND SAFETY OF A 14-DAY DOSING REGIMEN OF 3 DOSES OF ATB-346 VERSUS PLACEBO, ORALLY ADMINISTERED ONCE DAILY TO MALE AND FEMALE PATIENTS DIAGNOSED WITH OSTEOARTHRITIS OF THE KNEE

Registry ID

ATB-346-P2B-DRF

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

ANTIBE THERAPEUTICS INC

Start date

2019-05-27

Last update

2019-01-17

Conditions

• OSTEOARTHRITIS OF THE KNEE
• PAIN

Related clinical trials

• MASTER PROTOCOL: A MASTER PROTOCOL FOR PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE WEEKLY ELORALINTIDE IN ADULT PARTICIPANTS WITH OSTEOARTHRITIS KNEE PAIN, AND OBESITY OR OVERWEIGHT (ENLIGHTEN-4)
• EFFICACY AND SAFETY OF NNC0487-0111 S.C. ONCE-WEEKLY IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY, AND KNEE OSTEOARTHRITIS (AMAZE 6)
• EFFICACY AND SAFETY OF NNC0487-0111 S.C. ONCE-WEEKLY IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY, AND KNEE OSTEOARTHRITIS (AMAZE 5)
• A PHASE 3 STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ORFORGLIPRON ONCE DAILY IN PARTICIPANTS WHO HAVE OBESITY OR OVERWEIGHT AND OSTEOARTHRITIS OF THE KNEE: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED TRIAL (ATTAIN-OA PAIN)
• SINGLE DOSE PARALLEL COMPARATIVE BIOAVAILABILITY STUDY OF TRIAMCINOLONE HEXACETONIDE FOLLOWING INTRA-ARTICULAR ADMINISTRATION OF A SINGLE DOSE INJECTION OF TRIAMCINOLONE HEXACETONIDE (20 MG/ML) OR OF THE COMBINATION OF TRIAMCINOLONE HEXACETONIDE (18 MG/4 ML) AND CROSS-LINKED HYALURONIC ACID VISCOSUPPLEMENT IN MALE AND FEMALE PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
• KETAMINE ASSISTED PSYCHOTHERAPY TO IMPROVE QUALITY OF LIFE IN VETERANS AND CIVILIANS WITH COMORBID CHRONIC PAIN AND POSTTRAUMATIC STRESS DISORDER: AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL.

View on source registry